Drugs / Depigoid Parietaria judaica
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00916760 | Feb 2008 → Feb 2013 | allergic disease | Laboratorios Leti, S.L. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depigoid Parietaria judaica | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00916760 ↗ |
| Modality | Other / unclassified | “modified extract (depigmented and polymerized with glutaraldehyde)” NCT00916760 ↗ |
| Route | Subcutaneous | “Subcutaneous monthly treatment” NCT00916760 ↗ |